#resmed airsense 10 australia | Explore Tumblr posts and blogs

emilianoqtvp940-blog · 6 years ago

Text

Sleeping With Cpap Sleep Apnea Machines

If health is wealth, then sleep is just as important. Inadequate or lack of sleep can make anyone irritable, unfocused, and sensation low. Haven't you noticed that after a good night's sleep you see things in a better viewpoint? If you have sleep apnea, it's a different ball game, but CPAP accessories and masks can make your sleep better than ever.

When Do People Utilize Cpap Machines?

This disorder is most likely triggered by disorderly way of lives. If you consume a lot, cut it out. If you smoke a lot, cut it out. If you are constantly fatigued from work, take a break. There are more factors for it but it generally deals with tension. It will trigger your high blood pressure to go up and might make you feel tired buy resmed airmini all the time.

youtube

About 70% of the citizens signed onto the green initiative. When rebuilding began, energy-efficient windows, appliances, insulation, fuel-efficient heating and low-flow toilets were set up. They also developed storm shelters in their basements.

Snoring May Be Harmful To Your Life

Minimized daytime naps: As we all know, sleep apnea clients stay sleepy throughout the day. And if they are behind the wheels, they can be quite hazardous. By using Cpap masks Australia, they will get sound sleep throughout the nighttime. As a result, their daytime drowsiness will decrease and they will be able to pass the day without wishing to drop off to sleep. The quantity of sleep your body requirements will be met if you use a resmed airmini.

While harnessing wind power will assist you in your quest for a greener life, you might also be increasing the worth of your residential or commercial property. Green houses are all the rage nowadays, and a home with such setups currently included resmed airmini battery are hot residential or commercial properties.

Could You Be Struggling With A Sleep Resmed Airsense 10 Autoset Condition?

Likewise in the long run these machines have proven to not be as effective just since they are tough to utilize. Image sleeping with what looks to be a pilots mask for the rest of your life. I doubt you can. In reality many individuals provide up these gadgets before the year is out just merely since they are hard to deal with.

Establish a typical sleep regimen, and stay with it. Often, people who suffer from insomnia also have insomnia. If you can get on a schedule, your symptoms will be likely reduced by you. Make your sleeping quarters a welcoming location by changing the noises, lighting, and and smells around you.

#{Resmed Airsense 10 Autoset|Resmed Airsense 10 Autoset vs Elite|Resmed Airsense 10 Elite vs Autoset|Resmed Airmini Battery|Airmini Resmed|Bu

0 notes

katebrownell · 6 years ago

Text

Fisher and Paykel SleepStyle Preview

Finally, Fisher and Paykel have announced the release of their new CPAP machine: the Fisher and Paykel SleepStyle. I’ve personally had a lot of experience with the Icon range, so I am very interested to hear about it’s successor. Let’s see what Fisher and Paykel have done with the new SleepStyle.

Introducing the Fisher and Paykel SleepStyle (Specifications)

Released this month – the Fisher and Paykel SleepStyle is a discreet bedside CPAP unit with heated humidification. It is 6 years in the making, and is set to replace their aging Icon range.

Like it’s predecessor, the new SleepStyle is pitched to the upper echelon of the market – to do battle with ResMed’s AirSense and Respironics Dreamstation machines. Understandably then, it will be sold at a similar price point to these machines in Australia (and in the USA, we expect).

The machine itself has a relatively small profile, at 14.4 cm high, 17.7 cm wide, and 18.3 cm deep, taking up slightly more surface area on the bedside table compared to the AirSense 10 (and less than the DreamStation). It also weighs slightly more than the AirSense 10 machine at 2.7 kg packed up an ready to roll.

Improvements on the Icon Machines

Fisher and Paykel have basically redesigned the machine from the ground up, with an impressive amount of input from CPAP users and with a few overarching goals guiding its development. By liaising with CPAP patients, Fisher and Paykel identified four key areas, and set about designing a machine with these in mind.

These key areas are:

Simplicity

Easiness to Clean

Comfort Features

Innovative Technology

Read More - https://cpapreviews.org/fisher-and-paykel-sleepstyle-preview/

#cpap reviews #cpap machine #fisher and paykel sleepstyle

0 notes

healthcarebiz · 8 years ago

Text

New ResMed-sponsored Study Shows Promising Treatment Option for Patients with Untreated Central Sleep Apnea

- Largest-ever analysis of patients with treatment-emergent central sleep apnea shows switching from CPAP to ASV significantly improves compliance

- Study highlights the need to consider therapeutic options based on each patient's disease severity

MARSEILLES, France, April 6, 2017 /PRNewswire/ -- ResMed Inc. (NYSE: RMD) today announced that people with obstructive sleep apnea who develop central sleep apnea (CSA) are more compliant on therapy after they switch from continuous positive airway pressure (CPAP) therapy to adaptive servo-ventilation (ASV) therapy, according to the largest-ever analysis of patients with treatment-emergent CSA.

Experience the interactive Multimedia News Release here: http://ift.tt/2oMKoBB

The study analyzed anonymous, aggregated data from the devices of 198,890 telemonitored patients in the United States who were receiving positive airway pressure therapy for their sleep apnea. It showed that those with treatment-emergent CSA who switched from CPAP to ASV used their therapy longer and had significantly fewer apneas (breathing stoppages or reductions) during sleep:

62.7 percent: Patients' compliance on CPAP prior to switching

76.6 percent: The same patients' compliance after switching to ASV

"Achieving compliance through proper therapy usage is a well-recognized clinical goal in sleep apnea management, and one that is often hard to achieve, particularly in difficult-to-treat patients who may have untreated central sleep apnea," said Carlos Nunez, M.D., ResMed's Chief Medical Officer. "These findings underscore the importance of continuously monitoring central sleep apnea and rethinking the conventional wisdom on therapeutic options based on each patient's disease severity."

The study results were presented in an abstract at The European Respiratory Society and European Society of Sleep Research 2017 Sleep and Breathing conference in Marseilles, France. The opinion leaders and experts in the author group for the study include:

Jean-Louis Pepin from Institut National de la Sante et de la Recherche Medicale (INSERM), U 1042, HP2 Laboratory (Hypoxia: Pathophysiology), Grenoble Alpes University, Grenoble, France

Peter Cistulli from Charles Perkins Centre, University of Sydney, and Royal North Shore Hospital, Sydney, Australia

Atul Malhotra from University of California San Diego, La Jolla, California, USA

About the study This retrospective analysis compared compliance rates of 198,890 patients using anonymous, aggregated telemonitoring data from a U.S. positive airway pressure (PAP) therapy database. Three groups of patients were analyzed for compliance, device usage, and measures of disease severity: Those patients that started and stayed on CPAP (the "CPAP-only" group), patients that started and stayed on ASV (the "ASV-only" group), and patients that started on CPAP and switched to ASV (the "Switch" group). All patients in the analysis received CPAP via ResMed's AirSense™ 10 or ASV via ResMed's AirCurve™ 10 devices.

Compliance and device usage

The study used the U.S. Medicare definition of compliance: device usage for more than four hours per night on 70 percent of nights during a consecutive 30-day period anytime during the first three months of initial use.

In the "Switch" group, patients beginning on CPAP had the lowest initial compliance rate at 62.7 percent, but improved to 76.6 percent after switching to ASV. The low initial compliance seen in the Switch patients is possibly due to untreated CSA, based on their overall higher AHI -- specifically their central apnea index (CAI) -- during week one of therapy compared to the CPAP-only group. The 90-day compliance rates seen for the CPAP-only and ASV-only groups were 73.8 percent and 73.2 percent, respectively. In the Switch group, average residual AHI also decreased significantly (reduction from 17.2±0.9/h to 4.4±0.3/h) after the switch, indicating that ASV reduced both obstructive and central events.

Mean device usage at 90 days was similar for ASV in the Switch group with a rate of 5.73 hours per day, compared to 5.27 and 5.31 for the CPAP-only and ASV-only groups, respectively.

About sleep-disordered breathing Sleep-disordered breathing encompasses a spectrum of breathing problems during sleep, including sleep apnea, a condition that results in repetitive pauses in breathing during sleep. The two most common types are obstructive sleep apnea (OSA) and central sleep apnea (CSA). OSA is a sleep disorder in which the throat muscles relax, block the airways and stop the flow of breath during sleep. CSA is a sleep disorder in which the brain does not transmit the "breathe" signal to the muscles that control breathing during sleep.

In both OSA and CSA, the lack of oxygen causes the person to wake up and start breathing again, interrupting continuous sleep.

CSA specifically has been linked to a variety of diseases and conditions: It has been observed to develop over time – particularly in patients on CPAP for OSA who have a history of ischemic stroke or have taken opioids for chronic pain -- making it difficult to treat.

About ResMed ResMed (NYSE: RMD) changes lives with award-winning medical devices and cutting-edge cloud-based software applications that better diagnose, treat and manage sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed is a global leader in connected care, with more than 2 million patients remotely monitored every day. Our 5,000-strong team is committed to creating the world's best tech-driven medical device company -- improving quality of life, reducing the impact of chronic disease, and saving healthcare costs in more than 100 countries. ResMed.com | Facebook | Twitter | LinkedIn

Contacts:

For News Media

For Investors

Alison Graves

Agnes Lee

+1 858-836-6789

+1 858-836-5971

[email protected]

Logo - http://ift.tt/PjpaZF

Read this news on PR Newswire Asia website: New ResMed-sponsored Study Shows Promising Treatment Option for Patients with Untreated Central Sleep Apnea

#Healthcare

0 notes